Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Clinical Drug Investigation|April 25, 2023
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control StudyHaiyi Deng, Jiating Deng, Xinqing Lin, et al.Translational Lung Cancer Research|February 11, 2021
Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experienceXinqing Lin, Haiyi Deng, Likun Chen, et al.Frontiers in Immunology|December 24, 2024
Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberrationDu Feng, Huixin Jiang, Gengjia Chen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2019
A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lungZhanhong Xie, Laiyu Liu, Xinqing Lin, et al.Cell Reports. Medicine|October 7, 2025
Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trialXinqing Lin, Haiyi Deng, Nianxin Fang, et al.BMC Cancer|December 31, 2024
A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcomaTao Luan, Jianqing Hao, Yingying Gu, et al.Translational Lung Cancer Research|December 15, 2022
Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort studyXinqing Lin, Haiyi Deng, Tianqing Chu, et al.Human Vaccines & Immunotherapeutics|February 17, 2026
Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity TestTao Luan, Suneng Fu, Weiting Liu, et al.Journal for Immunotherapy of Cancer|September 12, 2025
Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitisHaiyi Deng, Yi Yang, Yilin Yang, et al.Translational Lung Cancer Research|June 15, 2026
Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancerTao Luan, Kangjing Ma, Shuaiying Wang, et al.Pageof 9